Invalda AB - Notification on material event

AB Invalda completes sale of part of AB Sanitas shares

On January 12, 2009, AB Invalda completed a transaction whereby it sold part of
its shares in AB Sanitas. 

Invalda had announced earlier that on October 24, 2008, the company signed
legal documentation regarding the sale of 6 314 502 shares, i.e. 20.3 % of the
share capital, of AB Sanitas for a total price of EUR30 mln to Baltic Pharma
Limited, an investment vehicle for funds managed by Citi Venture Capital
International (CVCI). 

The transaction was implemented in two stages: (a) 1 555 296 Sanitas shares, 5%
of share capital, were transferred for LTL 25.51 mln on October 28, 2008. (b)
Upon fulfillment of all necessary conditions precedent on January 12, 2009, the
balance of 4 759 206 shares (15.3%) were transferred for LTL 78.01 mln. 

As per the terms of the agreement with Baltic Pharma Limited, the price paid
for the shares and the number of shares transferred, may be adjusted upon a
future sale of the shares by Baltic Pharma Limited, depending on the price
received by the latter from such sale. 

Following this transaction, AB Invalda owns 25% of AB Sanitas' votes and
intends to retain this interest over the medium term. 

Darius Sulnis
President
+370 5 273 48 76